Ascendis Pharma (ASND) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Ascendis Pharma A/S, known for developing medical treatments for diseases, fully paid-up share capital stands at DKK 58,232,167, with shares at DKK 1 each. The company has exercised various authorizations to issue warrants and increase share capital, including issuing over 12 million warrants and allowing for share capital increases through cash contributions, contributions in kind, or conversions of debt at market price. Ascendis has also resolved to provide loans through convertible bonds, with the possibility of increasing share capital upon bond conversion without pre-emptive rights for existing shareholders.
For further insights into ASND stock, check out TipRanks’ Stock Analysis page.
